Pfizer 12. Juni 2026 US legislation targets China pharma IP licensing following multi-billion Pfizer, BMS deals - IAM Patent
Pfizer 10. Juni 2026 German pharma backlash deepens as Pfizer rethinks its investment plans - FirstWord Pharma
Pfizer 10. Juni 2026 Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters - Fierce Pharma
Pfizer 8. Juni 2026 Pfizer reports positive results from Phase IIb trial of berobenatide - Clinical Trials Arena
Pfizer 8. Juni 2026 Pharmalittle: We're reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more - statnews.com
Pfizer 4. Juni 2026 Pfizer gets a jump on Chai's new model, thanks to drug discovery pact - FirstWord Pharma
Pfizer 4. Juni 2026 Pfizer strikes $10.5 billion oncology deal with Chinese biotech - Life Sciences Intellectual Property Review
Pfizer 4. Juni 2026 Moderna Outshines Pharma Giants Lilly, Merck and Pfizer With 43% Year-to-Date Surge - NAI500
Pfizer 3. Juni 2026 Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - The Motley Fool
Pfizer 3. Juni 2026 Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026 - Yahoo Finance
Pfizer 30. Mai 2026 ASCO: In next-gen IO race, BioNTech/BMS and Pfizer are divided on overall survival approach - Fierce Biotech
Pfizer 30. Mai 2026 ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win - Fierce Pharma
Pfizer 20. Mai 2026 Pharma sector doubles down on AI amid hopes of slashing costs, timelines - Reuters